Cargando…
Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure
The pharmacological inhibition or genetic ablation of cyclophilin-D (CypD), a critical regulator of the mitochondrial permeability transition pore (mPTP), confers myocardial resistance to acute ischemia-reperfusion injury, but its role in post-myocardial infarction (MI) heart failure is unknown. The...
Autores principales: | Lim, Shiang Y, Hausenloy, Derek J, Arjun, Sapna, Price, Anthony N, Davidson, Sean M, Lythgoe, Mark F, Yellon, Derek M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350306/ https://www.ncbi.nlm.nih.gov/pubmed/21143389 http://dx.doi.org/10.1111/j.1582-4934.2010.01235.x |
Ejemplares similares
-
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning
por: Hausenloy, Derek J., et al.
Publicado: (2010) -
Rapid assessment of myocardial infarct size in rodents using multi-slice inversion recovery late gadolinium enhancement CMR at 9.4T
por: Price, Anthony N, et al.
Publicado: (2011) -
Reducing myocardial infarct size: challenges and future opportunities
por: Bulluck, Heerajnarain, et al.
Publicado: (2016) -
Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
por: Golforoush, Pelin, et al.
Publicado: (2020) -
SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart
por: Lim, Ven G., et al.
Publicado: (2019)